Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Sell
50
ADN.TO Quote, Financials, Valuation and Earnings
Last price:
$16.61
Seasonality move
:
5.4%
Day range:
$16.38 - $16.70
52-week range:
$13.98 - $18.43
Dividend yield:
6.98%
P/E ratio:
19.96x
P/S ratio:
3.49x
P/B ratio:
0.90x
Volume:
9.5K
Avg. volume:
14.6K
1-year change:
-4.81%
Market cap:
$303.7M
Revenue:
$116.2M
EPS (TTM):
$0.83
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $91M | $95.7M | $90.5M | $93.5M | $116.2M | |
| Revenue Growth (YoY) | -9.01% | 5.16% | -5.49% | 3.32% | 24.29% | |
| Cost of Revenues | $61.2M | $65.2M | $63.2M | $64.3M | $78.4M | |
| Gross Profit | $29.9M | $30.5M | $27.3M | $29.2M | $37.7M | |
| Gross Profit Margin | 32.8% | 31.9% | 30.18% | 31.26% | 32.49% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $9M | $8.8M | $9.4M | $9.7M | $14.1M | |
| Other Inc / (Exp) | $14.7M | $7.7M | $34.4M | $23.6M | $10.5M | |
| Operating Expenses | $9M | $8.8M | $9.4M | $9.7M | $14.1M | |
| Operating Income | $20.8M | $21.8M | $17.9M | $19.6M | $23.7M | |
| Net Interest Expenses | $4.3M | $3M | $3.1M | $3.2M | $3.1M | |
| EBT. Incl. Unusual Items | $31.3M | $26.5M | $49.1M | $40M | $31M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $9.2M | $7.8M | $13.6M | $10.6M | $9.3M | |
| Net Income to Company | $22.1M | $18.7M | $35.5M | $29.4M | $21.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $22.1M | $18.7M | $35.5M | $29.4M | $21.7M | |
| Basic EPS (Cont. Ops) | $1.32 | $1.12 | $2.11 | $1.72 | $1.24 | |
| Diluted EPS (Cont. Ops) | $1.32 | $1.12 | $2.11 | $1.72 | $1.24 | |
| Weighted Average Basic Share | $16.7M | $16.7M | $16.8M | $17.1M | $17.6M | |
| Weighted Average Diluted Share | $16.7M | $16.7M | $16.8M | $17.1M | $17.6M | |
| EBITDA | $21.1M | $22M | $18.1M | $19.9M | $24.2M | |
| EBIT | $20.8M | $21.8M | $17.9M | $19.6M | $23.7M | |
| Revenue (Reported) | $91M | $95.7M | $90.5M | $93.5M | $116.2M | |
| Operating Income (Reported) | $20.8M | $21.8M | $17.9M | $19.6M | $23.7M | |
| Operating Income (Adjusted) | $20.8M | $21.8M | $17.9M | $19.6M | $23.7M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $24.5M | $23.6M | $26.6M | $26M | $23M | |
| Revenue Growth (YoY) | 5.39% | -3.65% | 12.71% | -2.38% | -11.33% | |
| Cost of Revenues | $16.8M | $16.3M | $18.7M | $18.4M | $17.2M | |
| Gross Profit | $7.6M | $7.3M | $7.9M | $7.5M | $5.8M | |
| Gross Profit Margin | 31.22% | 30.75% | 29.72% | 28.95% | 25.36% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.6M | $2.8M | $3.2M | $3.6M | $3.4M | |
| Other Inc / (Exp) | -$2.7M | $3M | $3.7M | -$91K | -- | |
| Operating Expenses | $2.6M | $2.8M | $3.2M | $3.6M | $2.9M | |
| Operating Income | $5M | $4.4M | $4.7M | $3.9M | $3M | |
| Net Interest Expenses | $748K | $795K | $795K | $654K | $1M | |
| EBT. Incl. Unusual Items | $1.6M | $6.6M | $7.6M | $3.2M | $3.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.3M | $1.8M | $1.2M | $939K | $171K | |
| Net Income to Company | $344K | $4.8M | $6.4M | $2.2M | $2.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $344K | $4.8M | $6.4M | $2.2M | $2.9M | |
| Basic EPS (Cont. Ops) | $0.02 | $0.29 | $0.37 | $0.13 | $0.16 | |
| Diluted EPS (Cont. Ops) | $0.02 | $0.29 | $0.37 | $0.13 | $0.16 | |
| Weighted Average Basic Share | $16.7M | $16.8M | $17.1M | $17.5M | $18.1M | |
| Weighted Average Diluted Share | $16.7M | $16.8M | $17.1M | $17.5M | $18.1M | |
| EBITDA | $5.1M | $4.5M | $4.8M | $4M | $3.5M | |
| EBIT | $5M | $4.4M | $4.7M | $3.9M | $3M | |
| Revenue (Reported) | $24.5M | $23.6M | $26.6M | $26M | $23M | |
| Operating Income (Reported) | $5M | $4.4M | $4.7M | $3.9M | $3M | |
| Operating Income (Adjusted) | $5M | $4.4M | $4.7M | $3.9M | $3M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $94.7M | $95.5M | $93.4M | $119.8M | $85.2M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $63.9M | $65.6M | $64.5M | $81.1M | $61.5M | |
| Gross Profit | $30.8M | $29.8M | $28.9M | $38.6M | $23.8M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $8.4M | $9.4M | $9.7M | $13.9M | $12.8M | |
| Other Inc / (Exp) | $17.2M | $11.5M | $37.9M | $18M | -- | |
| Operating Expenses | $8.4M | $9.4M | $9.7M | $13.9M | $11.5M | |
| Operating Income | $22.4M | $20.4M | $19.2M | $24.8M | $12.3M | |
| Net Interest Expenses | $2.9M | $3M | $3.2M | $3.2M | $3.7M | |
| EBT. Incl. Unusual Items | $36.7M | $28.9M | $54M | $39.6M | $19.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $9.2M | $8.5M | $14.1M | $11.9M | $4.8M | |
| Net Income to Company | $27.5M | $20M | $39.8M | $27.7M | $14.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $27.5M | $20.4M | $39.8M | $27.7M | $14.8M | |
| Basic EPS (Cont. Ops) | $1.65 | $1.22 | $2.35 | $1.61 | $0.83 | |
| Diluted EPS (Cont. Ops) | $1.65 | $1.22 | $2.35 | $1.61 | $0.83 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $22.7M | $20.7M | $19.5M | $25.2M | $13.8M | |
| EBIT | $22.4M | $20.4M | $19.2M | $24.8M | $12.3M | |
| Revenue (Reported) | $94.7M | $95.5M | $93.4M | $119.8M | $85.2M | |
| Operating Income (Reported) | $22.4M | $20.4M | $19.2M | $24.8M | $12.3M | |
| Operating Income (Adjusted) | $22.4M | $20.4M | $19.2M | $24.8M | $12.3M | |
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2026-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $66.7M | $69.7M | $96M | $65M | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $45.6M | $46.9M | $63.8M | $46.8M | -- | |
| Gross Profit | $21.2M | $22.8M | $32.2M | $18.2M | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $7.2M | $7.5M | $11.7M | $10.5M | -- | |
| Other Inc / (Exp) | $7.2M | $10.8M | $5.2M | $4.5M | -- | |
| Operating Expenses | $7.2M | $7.5M | $11.7M | $9.1M | -- | |
| Operating Income | $13.9M | $15.3M | $20.4M | $9.1M | -- | |
| Net Interest Expenses | $2.3M | $2.4M | $2.4M | $2.9M | -- | |
| EBT. Incl. Unusual Items | $18.8M | $23.7M | $23.2M | $11.9M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $5.3M | $5.8M | $7.1M | $2.6M | -- | |
| Net Income to Company | $13.5M | $17.8M | $16.2M | $9.3M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $13.5M | $17.8M | $16.2M | $9.3M | -- | |
| Basic EPS (Cont. Ops) | $0.81 | $1.05 | $0.93 | $0.52 | -- | |
| Diluted EPS (Cont. Ops) | $0.81 | $1.05 | $0.93 | $0.52 | -- | |
| Weighted Average Basic Share | $50.2M | $51.1M | $52.1M | $53.8M | -- | |
| Weighted Average Diluted Share | $50.2M | $51.1M | $52.1M | $53.8M | -- | |
| EBITDA | $14.1M | $15.5M | $20.8M | $10.4M | -- | |
| EBIT | $13.9M | $15.3M | $20.4M | $9.1M | -- | |
| Revenue (Reported) | $66.7M | $69.7M | $96M | $65M | -- | |
| Operating Income (Reported) | $13.9M | $15.3M | $20.4M | $9.1M | -- | |
| Operating Income (Adjusted) | $13.9M | $15.3M | $20.4M | $9.1M | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $10.3M | $7.3M | $6.2M | $1.8M | $15.3M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $7.7M | $8.4M | $8.3M | $9.3M | $8.6M | |
| Inventory | $957K | $1.5M | $1.9M | $15.3M | $2.1M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $19.4M | $17.3M | $16.3M | $28.1M | $25.9M | |
| Property Plant And Equipment | $487.9M | $493.2M | $525.4M | $533.7M | $576M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $388M | $394.1M | $437.4M | $442.8M | $471.9M | |
| Total Assets | $513.4M | $516.6M | $547.8M | $568M | $608M | |
| Accounts Payable | $8.6M | $8.8M | $11.2M | $9.4M | $10.9M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $13.5M | $13.6M | $16.1M | $14.4M | $62.3M | |
| Long-Term Debt | $101.2M | $100.9M | $107.9M | $105.5M | $68.9M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $220.2M | $225.2M | $244.1M | $249M | $269M | |
| Common Stock | $139.4M | $139.4M | $142.8M | $147.6M | $156.3M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $293.2M | $291.5M | $303.7M | $319M | $339M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $293.2M | $291.5M | $303.7M | $319M | $339M | |
| Total Liabilities and Equity | $513.4M | $516.6M | $547.8M | $568M | $608M | |
| Cash and Short Terms | $10.3M | $7.3M | $6.2M | $1.8M | $15.3M | |
| Total Debt | $101.2M | $100.9M | $107.9M | $105.5M | $114.9M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $10.5M | $3.8M | $2.7M | $14.6M | $2.4M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $7.4M | $13.5M | $12M | $10.5M | -- | |
| Inventory | $853K | $943K | $15.4M | $1.6M | $2.1M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $18.7M | $18.7M | $32.1M | $26.7M | $13.4M | |
| Property Plant And Equipment | $489.9M | $512.3M | $521.9M | $552.6M | $583M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $390.1M | $409.9M | $433.7M | $457.9M | -- | |
| Total Assets | $514.8M | $537.1M | $560M | $585.4M | $602.7M | |
| Accounts Payable | $11.1M | $12.2M | $12.2M | $12.7M | $9.2M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | $43.2M | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $16M | $17.1M | $17.2M | $61.7M | $15.2M | |
| Long-Term Debt | $100.9M | $108.1M | $107.8M | $64.6M | $112M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $224.6M | $242M | $249.6M | $257.7M | $264.3M | |
| Common Stock | $139.4M | $141.6M | $146.4M | $153.8M | $164M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $290.2M | $295.1M | $310.4M | $327.8M | $338.4M | |
| Total Liabilities and Equity | $514.8M | $537.1M | $560M | $585.4M | $602.7M | |
| Cash and Short Terms | $10.5M | $3.8M | $2.7M | $14.6M | $2.4M | |
| Total Debt | $100.9M | $108.1M | $107.8M | $107.8M | $112.8M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $22.1M | $18.7M | $35.5M | $29.4M | $21.7M | |
| Depreciation & Amoritzation | $280K | $261K | $273K | $363K | $517K | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $3.9M | -$655K | $121K | -$1M | $725K | |
| Change in Inventories | $588K | -$493K | -$400K | $514K | -$501K | |
| Cash From Operations | $20.1M | $16.2M | $15.2M | $10.4M | $34M | |
| Capital Expenditures | $351K | $333K | $378K | $619K | $10.5M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $32K | $186K | -$319K | $56K | -$9.1M | |
| Dividends Paid (Ex Special Dividend) | $19.4M | $19.4M | $16M | $14.9M | $11.5M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $106.5M | -- | -- | -- | $10.3M | |
| Long-Term Debt Repaid | -$104.6M | -- | -- | -- | -$10.3M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$532K | -- | -- | -- | -- | |
| Cash From Financing | -$17.5M | -$19.4M | -$16M | -$14.9M | -$11.5M | |
| Beginning Cash (CF) | $10.3M | $7.3M | $6.2M | $1.8M | $15.3M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.7M | -$2.9M | -$1.1M | -$4.4M | $13.4M | |
| Ending Cash (CF) | $12.9M | $4.4M | $5.1M | -$2.6M | $28.7M | |
| Levered Free Cash Flow | $19.7M | $15.9M | $14.9M | $9.8M | $23.5M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $344K | $4.8M | $6.4M | $2.2M | $2.9M | |
| Depreciation & Amoritzation | $66K | $74K | $106K | $139K | $552K | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$864K | -$7.6M | -$5.5M | -$2.8M | $232K | |
| Change in Inventories | -$239K | -$217K | -$371K | $182K | -$924K | |
| Cash From Operations | $7.3M | $852K | $2.8M | $5.1M | $2.7M | |
| Capital Expenditures | $148K | $148K | $373K | $292K | $149K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $191K | -$148K | -$293K | -$291K | -$130K | |
| Dividends Paid (Ex Special Dividend) | $4.8M | $3.7M | $3.7M | $2.6M | $2.6M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$4.8M | -$3.7M | -$3.7M | -$2.6M | -$2.8M | |
| Beginning Cash (CF) | $10.5M | $3.8M | $2.7M | $14.6M | $2.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.6M | -$3M | -$1.3M | $2.2M | -$219K | |
| Ending Cash (CF) | $13.1M | $741K | $1.5M | $16.8M | $2.2M | |
| Levered Free Cash Flow | $7.1M | $704K | $2.4M | $4.8M | $2.5M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $27.5M | $20M | $39.8M | $27.7M | $14.8M | |
| Depreciation & Amoritzation | $266K | $263K | $341K | $470K | $1.5M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $2.8M | -$5.8M | $1.5M | $1.5M | $2.4M | |
| Change in Inventories | $325K | -$90K | -$174K | -$653K | -$118K | |
| Cash From Operations | $21.9M | $10.6M | $13.8M | $34.5M | $4.6M | |
| Capital Expenditures | $304K | $279K | $677K | $10.2M | $3.5M | |
| Cash Acquisitions | -- | -- | -- | -- | $6.5M | |
| Cash From Investing | $493K | -$160K | $38K | -$10M | -$8.2M | |
| Dividends Paid (Ex Special Dividend) | $19.4M | $17.1M | $14.9M | $12.6M | $10.4M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | $10.3M | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -$10.3M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$19.4M | -$17.1M | -$14.9M | -$12.6M | -$8.6M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $3M | -$6.7M | -$1M | $11.9M | -$12.2M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $21.6M | $10.3M | $13.1M | $24.3M | $1.1M | |
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2026-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $13.5M | $17.8M | $16.2M | $9.3M | -- | |
| Depreciation & Amoritzation | $194K | $262K | $369K | $1.4M | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$5.1M | -$3.7M | -$1.2M | $478K | -- | |
| Change in Inventories | $507K | $733K | -$434K | -$51K | -- | |
| Cash From Operations | $9M | $7.5M | $31.6M | $2.2M | -- | |
| Capital Expenditures | $251K | $550K | $10.2M | $3.1M | -- | |
| Cash Acquisitions | -- | -- | -- | $6.5M | -- | |
| Cash From Investing | -$237K | $120K | -$9.9M | -$9M | -- | |
| Dividends Paid (Ex Special Dividend) | $12.3M | $11.2M | $8.9M | $7.8M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $10.3M | $2.2M | -- | |
| Long-Term Debt Repaid | -- | -- | -$10.3M | -$220K | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$12.3M | -$11.2M | -$8.9M | -$6M | -- | |
| Beginning Cash (CF) | $17.6M | $10.4M | $31.1M | $9.7M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$3.6M | -$3.5M | $12.8M | -$12.8M | -- | |
| Ending Cash (CF) | $14.1M | $6.9M | $43.9M | -$3.1M | -- | |
| Levered Free Cash Flow | $8.7M | $7M | $21.5M | -$937K | -- | |
Get ADN.TO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ADN.TO
Sector
P/E ratio
19.96x
19.88x
PEG ratio
0.08x
-0.02x
P/B ratio
0.90x
1.85x
Price / LTM sales
3.49x
1.65x
Growth Metrics
ADN.TO
Sector
Revenue growth
-11.33%
2.4%
Earnings growth
27.91%
--
Revenue (5-year growth)
3.04%
3.24%
Earnings forecast
$0.05
$0.03
Profitability
ADN.TO
Sector
Profitability FY 2024
$37.7M
--
Return on invested capital
3.31%
-9.18%
Return on assets
2.47%
-10.59%
Return on equity
4.41%
-9.79%
Earnings Date
Last Earnings Date
Oct
29
Next Earnings Date
Feb
11
Estimated Next Earnings Date
Jan
28
Balance Sheet
ADN.TO
Sector
Total cash
$2.4M
$2.6M
Short term investments
--
$217K
Total assets
$608M
$16.7M
Long term debt
$112.8M
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
53
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 30x
Alerts
Buy
67
PRLB alert for Feb 10
Proto Labs, Inc. [PRLB] is down 2.16% over the past day.
Sell
33
MSTR alert for Feb 10
Strategy, Inc. [MSTR] is up 2.59% over the past day.
Sell
10
MOH alert for Feb 10
Molina Healthcare, Inc. [MOH] is down 3% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
